Elite in Angiodysplasia of the Colon

Joost P. Drenth

RadboudUMC
Nijmegen, GE, NL 
Elite in Angiodysplasia of the Colon
RadboudUMC
Nijmegen, GE, NL 
OverviewLocationsClinical Research

Overview

Joost Drenth practices in Nijmegen, Netherlands. Drenth is rated as an Elite expert by MediFind in the treatment of Angiodysplasia of the Colon. Their top areas of expertise are Erythromelalgia, Angiodysplasia of the Colon, Autoimmune Hepatitis, Gallbladder Removal, and Endoscopy.

Their clinical research consists of co-authoring 434 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 10 articles in the study of Angiodysplasia of the Colon.

Locations

RadboudUMC
Nijmegen, GE 6525GA, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
Development and Assessment of the Psychometric Properties of a Polycystic Liver Disease-specific Patient Reported Outcomes Questionnaire (PLD-Q).
Development and Assessment of the Psychometric Properties of a Polycystic Liver Disease-specific Patient Reported Outcomes Questionnaire (PLD-Q).
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Other
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
Enrollment Status: Terminated
Publish Date: March 09, 2023
Intervention Type: Drug
Study Drug: Obeticholic Acid 
Study Phase: Phase 4
View 2 Less Clinical Trials

434 Total Publications

Exploring the Role of the Gut Microbiome Across the Lifespan: Implications for Aging and Metabolic Disorders.
Exploring the Role of the Gut Microbiome Across the Lifespan: Implications for Aging and Metabolic Disorders.
Journal: Journal of the Endocrine Society
Published: April 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Drenth's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 15 Advanced Conditions
View All 46 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile